Intellicheck, Inc. (NYSE:IDN - Free Report) - Investment analysts at HC Wainwright issued their FY2025 earnings per share estimates for shares of Intellicheck in a research report issued to clients and investors on Wednesday, August 13th. HC Wainwright analyst S. Buck anticipates that the company will post earnings per share of ($0.04) for the year. HC Wainwright currently has a "Buy" rating and a $6.00 target price on the stock. The consensus estimate for Intellicheck's current full-year earnings is ($0.09) per share. HC Wainwright also issued estimates for Intellicheck's Q4 2025 earnings at $0.01 EPS and FY2026 earnings at $0.00 EPS.
Several other brokerages also recently commented on IDN. Wall Street Zen raised Intellicheck from a "hold" rating to a "buy" rating in a research note on Wednesday, June 18th. DA Davidson set a $6.50 price objective on Intellicheck and gave the stock a "buy" rating in a research note on Wednesday. Finally, Craig Hallum raised Intellicheck from a "hold" rating to a "buy" rating and set a $6.00 price objective on the stock in a research note on Wednesday, May 21st.
View Our Latest Stock Report on IDN
Intellicheck Stock Down 1.6%
Intellicheck stock traded down $0.08 during mid-day trading on Friday, hitting $4.76. 27,934 shares of the company's stock were exchanged, compared to its average volume of 210,348. The firm has a market capitalization of $94.48 million, a P/E ratio of -158.70 and a beta of 1.21. Intellicheck has a fifty-two week low of $1.92 and a fifty-two week high of $6.49. The company's 50 day simple moving average is $5.26 and its 200-day simple moving average is $3.73.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in the company. Geode Capital Management LLC increased its holdings in shares of Intellicheck by 4.8% during the fourth quarter. Geode Capital Management LLC now owns 199,835 shares of the company's stock worth $560,000 after buying an additional 9,166 shares in the last quarter. Renaissance Technologies LLC increased its holdings in shares of Intellicheck by 9.5% during the fourth quarter. Renaissance Technologies LLC now owns 114,000 shares of the company's stock worth $319,000 after buying an additional 9,900 shares in the last quarter. Topline Capital Management LLC acquired a new position in shares of Intellicheck during the fourth quarter worth $3,248,000. Northern Trust Corp increased its holdings in shares of Intellicheck by 20.7% during the fourth quarter. Northern Trust Corp now owns 33,925 shares of the company's stock worth $95,000 after buying an additional 5,827 shares in the last quarter. Finally, Captrust Financial Advisors acquired a new position in shares of Intellicheck during the fourth quarter worth $676,000. 42.79% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In related news, Director Gregory Braca sold 7,703 shares of the business's stock in a transaction that occurred on Thursday, May 22nd. The stock was sold at an average price of $4.33, for a total value of $33,353.99. Following the completion of the sale, the director directly owned 823 shares in the company, valued at approximately $3,563.59. The trade was a 90.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 6.88% of the company's stock.
About Intellicheck
(
Get Free Report)
Intellicheck, Inc, a technology company, provides on-demand digital identity validation solutions for KYC, fraud, and age verification needs in North America. The company offers solutions for digital and physical identities for financial services, fintech companies, BNPL providers, e-commerce and retail commerce businesses, law enforcement, and government agencies.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Intellicheck, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intellicheck wasn't on the list.
While Intellicheck currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.